Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

MedLumics unveils new skin imaging system

Spain-based medical imaging company MedLumics has introduced a new Nitid skin imaging system at the 23rd Annual European Academy of Dermatology and Venereology Congress in Amsterdam, Netherlands.

Nitid is a handheld diagnostic device, which was developed to help dermatologists to quickly diagnose skin cancer.

MedLumics CEO Eduardo Margallo said that Nitid is the result of a decade of research in optical miniaturization technology.

"Nitid integrates three imaging modalities in one easy-to-use probe, thereby enabling physicians to produce high-quality images of a patient’s skin and determine whether skin cancer is present without an invasive biopsy," Margallo added.

MedLumics noted that Nitid will be the first point-of-care optical coherence tomography (OCT) imaging device that can produce high-resolution diagnostic images with tissue penetration capability of up to 2mm, once approved by regulatory bodies.

The device aggregates epiluminescence microscopy and OCT imagery in a patent-protected built-in display, and integrates with current patient-centered workflows.

It provides complete solution to patient and image management by supporting lesion mapping and follow-up, as well as device allows physicians to use throughout their offices.